Cleared Special

K233562 - LINQ II Insertable Cardiac Monitor (FDA 510(k) Clearance)

Dec 2023
Decision
30d
Days
Class 2
Risk

K233562 is an FDA 510(k) clearance for the LINQ II Insertable Cardiac Monitor. This device is classified as a Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection) (Class II - Special Controls, product code MXD).

Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on December 6, 2023, 30 days after receiving the submission on November 6, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1025.

Submission Details

510(k) Number K233562 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 2023
Decision Date December 06, 2023
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MXD — Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1025

Similar Devices — MXD Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)

All 14
Assert-IQ (DM5100)
K253516 · Abbott Medical · Dec 2025
LUX-Dx II Insertable Cardiac Monitor (M302)
K252593 · Boston Scientific Corporation · Sep 2025
LINQ II™ Insertable Cardiac Monitor (ICM)
K240693 · Medtronic, Inc. · Mar 2024
LINQ II™ Insertable Cardiac Monitor (LNQ22)
K233320 · Medtronic, Inc. · Oct 2023
LUX-Dx II (M302)
K231328 · Boston Scientific Corp · Aug 2023
BIOMONITOR IV
K230375 · Biotronik, Inc. · May 2023